The prevalence and characteristics of sleep-disordered breathing (SDB) in patients with ventricular arrhythmias, such as premature ventricular complexes (PVCs) and ventricular tachycardia (VT), are unknown. Therefore, we evaluated the prevalence of SDB in patients with severe ventricular arrhythmias and normal left ventricular (LV) function. Thirty-five patients (63% men; mean age: 57.4 ± 13.8 years) underwent a sleep study. All patients had VT or frequent PVCs (≥300 PVCs/h) and had been referred to the Cardiology Department for medication, catheter ablation therapy, or implantation of a cardioverter/defibrillator. We excluded heart failure patients with an LV ejection fraction <50%; in the remaining patients, mean LVEF was 63.9 ± 8.0%. Twenty-one patients (60%) had SDB with an apnea-hypopnea index (AHI) ≥5, and the average AHI was 22.7 ± 17.9/h. Twelve patients (34%) had moderate to severe SDB with an average AHI of 33.6 ± 16.6/h. Central dominant sleep apnea was evident in 3 patients with SDB.
Introduction
Some previously reported studies that analyzed the occurrence of sleep-disordered breathing (SDB) with ventricular arrhythmias involved only patients with heart failure. [1] [2] [3] In patients with heart failure, ventricular arrhythmias occur frequently not only because of SDB but also cardiac dysfunction itself, resulting in sympathetic nerve activity. 4 Other studies have reported a high occurrence of ventricular arrhythmias in patients with SDB. 5, 6 We tested the hypothesis that patients with ventricular arrhythmias are more likely to have SDB even without heart failure. We studied 35 patients with ventricular arrhythmias who did not have major comorbid disorders that could contribute to sleep disruption or desaturation. This study examined the prevalence and severity of SDB in patients having ventricular arrhythmias without heart failure.
Methods

Study population:
We prospectively studied consecutive patients referred to the Apnea was defined as cessation of inspiration for at least 10 seconds. All such events were counted irrespective of the degree of oxygen desaturation or presence of an arousal. Obstructive apnea was defined as the absence of airflow in the presence of rib cage and/or abdominal excursions. Central apnea was defined as the absence of rib cage and abdominal excursions with absence of airflow. Hypopnea was defined as a reduction in airflow by at least 30% with a decrease in oxygen saturation (SaO 2 ) by 4%
or more for at least 10 seconds in the presence of thoracoabdominal ventilatory efforts.
The apnea-hypopnea index (AHI) was calculated as the sum of apneic and hypopneic events per hour of sleep. 7 The diagnosis of central sleep apnea required an AHI ≥5/h, with more than 50% of the events determined to be central rather than obstructive. We used an AHI of 5/h as the threshold. Mild SDB was defined as 5/h ≤ AHI < 15/h, moderate SDB was defined as 15 ≤ AHI < 30/h, and severe SDB was defined as AHI ≥30/h.
Epworth Sleepiness Scale: The Epworth Sleepiness Scale (ESS) is a frequently used,
8-item, self-administered subjective measure of sleepiness. The subject rates, on a scale of 0-3, the likelihood that he or she will doze off or fall asleep during 8 different situations commonly encountered in daily life. Scores are tallied across the 8 items to compute an ESS score; an ESS score ≥11 is considered indicative of subjective sleepiness. This scale has previously shown a high level of internal consistency among its 8 items, high test-retest reliability, and the ability to distinguish patients with excessive daytime sleepiness from normal subjects. 
Results
The frequency distribution of the AHI in 5/h-to 15/h-unit intervals for the 35 patients with ventricular arrhythmia is depicted in Figure 1 . Twenty-one of 35 patients (60%)
had SDB, with mild SDB noted in 26% of patients (mean AHI: 8.2 ± 2.5/h), moderate SDB in 14% (mean AHI: 21.8 ± 3.7/h), and severe SDB in 20% (mean AHI: 45.5 ±
16
.0/h). The clinical characteristics of both groups are summarized in Table 1 . The difference in sexes between patients with and without SDB was not statistically significant. Patients with SDB were older than those without SDB, and their BMI and waist circumference were significantly higher than those of patients without SDB. No statistical differences were noted in rates of obesity (BMI ≥30), hypertension, diabetes mellitus, hyperlipidemia, and cardiac disease between the 2 groups. Mean ESS score was <11 in both groups and was not statistically different between the 2 groups. There was no difference in the type of ventricular arrhythmias and the day-night pattern of the arrhythmias between the groups, as shown in Table 2 . The results of the sleep study are presented in Table 3 . Comparison of patients with and without SDB showed that SDB 7 patients had significantly increased arousal index and percent SaO 2 <90% and significantly decreased mean and lowest SaO 2 . The clinical characteristics of the 12 patients with moderate to severe SDB are shown in Table 4 . Three of these patients had predominantly central sleep apnea: mean central apnea AHI was 17.0 ± 6.6/h. Three patients had ventricular arrhythmia occurring during night rather than day.
Discussion
The novel findings of the present study are that approximately 60% of patients with ventricular arrhythmias had SDB. This is the first report to show a strong association between SDB and ventricular arrhythmias in patients without heart failure. Among such patients, mild SDB was diagnosed in 26% and moderate to severe SDB in 34%. To our knowledge, no data are available regarding the prevalence of SDB in patients with ventricular arrhythmias occurring without heart failure, although several prior studies showed a relation between SDB and ventricular arrhythmia complicated by heart failure. [1] [2] [3] Because impaired heart function increases sympathetic activity, resulting in ventricular arrhythmia, 4 heart failure is thought to exacerbate ventricular arrhythmia.
However, the contribution of SDB to sympathetic activity in patients with ventricular arrhythmia and normal cardiac function has not been extensively discussed. In this study, 8 all participants had clinically severe ventricular arrhythmias without heart failure.
Interestingly, there was no difference either in ESS score or number of patients with ESS score ≥11. This result showed that patients had no symptoms of daytime sleepiness even with SDB. Among subjects participating in the Sleep Heart Health Study, although there was a strong association of AHI with self-reported sleepiness, the majority of subjects with an AHI ≥5 did not report excessive sleepiness, 13 indicating that self-reporting measures may underestimate the severity of sleepiness in the setting of hypersomnolence.
Another novel finding of this study involved BMI in the patients with SDB; our patients had a mean BMI 26.3 ± 4.0 kg/m 2 , with 19% having a BMI >30. Compared with previous reports [8] [9] [10] from Western nations, data from patients with SDB in the present study revealed a lower BMI and low rate of obesity. One report has estimated the prevalence of obstructive sleep apnea (OSA) in an Asian population. 11 Kim et al 12 reported the prevalence of SDB in Korea was 27% in men and 16% and women, and mean BMI was 26.5 ± 2.9 in men and 26.9 ± 4.1 in women. These are provocative results because obesity, a strong risk factor for SDB, is prevalent in white populations, but is relatively uncommon in Asian countries.
In addition, 3 of the SDB patients experienced ventricular arrhythmia more often at night than during the day, suggesting that conditions associated with SDB may lead to ventricular arrhythmias. Gami et al 18 reported that people with SDB have a peak in sudden death from cardiac causes during the sleeping hours, which contrasts strikingly with the nadir of sudden death from cardiac causes during this period in people without SDB. In the present study, one of the patients without SDB was also found to have ventricular arrhythmia more often at night than during the day. This patient showed an <60%, a significant increase in PVC frequency was detected with decreasing SaO 2 . In patients with SDB, they suggested that repetitive obstructions to normal breathing during sleep induce hypoxemia and hypercapnia, which (acting through the chemoreflexes) elicit increased sympathetic activity that induces ventricular arrhythmias.
Altered cardiovascular variability affects predominantly patients with moderate to severe sleep apnea. [23] [24] [25] [26] [27] In SDB patients, ventilation and blood pressure increase substantially during hypoxic breathing. Peripheral chemoreceptors, which primarily respond to blood oxygen, are detected with high sensitivity in SDB. In SDB patients, the chemoreflex appears to be a potent mechanism for sympathetic activation, overriding the combined restraining influences of increased blood pressure and increased ventilation. Enhanced chemoreflex sensitivity in SDB may explain the exaggerated sympathetic response during hypoxemic episodes resulting in autonomic activity-dependent arrhythmias. [28] [29] [30] Our study had several limitations. First, due to technical limitations, oxygen saturation monitoring results of the patients with frequent PVCs were excluded because these data were thought to be underestimated. However, hypopnea could be analyzed by the occurrence of at least 50% reduction in airflow lasting at least 10 seconds with an arousal. Second, the diagnosis of sleep apnea was provided by a study based on a single night in a sleep laboratory. However, this is the standard procedure followed for the 11 diagnosis of sleep apnea in the clinical setting. Third, there is no control group.
However, compared to the previous epidemiologic studies, 11, 12 prevalence of SDB was revealed to be significantly high in this study. 
